Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Hosp Palliat Care ; 36(12): 1105-1113, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31122031

RESUMO

BACKGROUND: Palliative care services and life-sustaining treatments are provided to dying patients with lung cancer in the United States. However, data on the utilization trends of palliative care services and life-sustaining treatments of dying patients with lung cancer are not available. METHODS: This study was a retrospective analysis of the National Inpatient Sample data (2005-2014) and included patients with lung cancer, aged ≥ 18 years, who died in the hospitals. Claims data of palliative care services and life-sustaining treatments that contained systemic procedures, local procedures, or surgeries were extracted. Compound annual growth rates (CAGRs) using Rao-Scott correction for χ2 tests were used to determine the statistical significance of temporal utilization trends of palliative care services and life-sustaining treatments and their hospital costs. Multilevel multivariate regressions were performed to identify factors associated with hospital costs. RESULTS: A total of 120 144 weighted patients with lung cancer died in the hospitals and 41.9% of them received palliative care services. The CAGRs of systemic procedures, local procedures, surgeries, palliative care services, and hospital cost were 3.42%, 3.48%, 6.08%, 18.5%, and 5.0% (all P < .001), respectively. Increased hospital cost was attributed to systemic procedures (50.6%), local procedures (74.4%), and surgeries (68.5%; all P < .001), respectively. Palliative care services were related to decreasing hospital costs by 28.6% (P < .001). CONCLUSION: The temporal trends of palliative care services indicate that their utilization has increased gradually. Palliative care services were associated with reduced hospital costs. However, life-sustaining treatments were associated with increased hospital costs.


Assuntos
Custos Hospitalares/estatística & dados numéricos , Neoplasias Pulmonares/terapia , Cuidados Paliativos/estatística & dados numéricos , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Assistência Terminal/estatística & dados numéricos , Idoso , Feminino , Humanos , Tempo de Internação , Neoplasias Pulmonares/economia , Masculino , Cuidados Paliativos/economia , Estudos Retrospectivos , Assistência Terminal/economia , Estados Unidos/epidemiologia
2.
J Coll Physicians Surg Pak ; 26(6 Suppl): S33-4, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27376214

RESUMO

The majority of dengue viral infections are asymptomatic, though symptoms may range from self-limiting febrile illness to life threatening hemorrhagic manifestations. As the burden of disease is dramatically rising in recent years, more patients with atypical presentations and rare complications are increasingly reported. Dengue virus may rarely involve different organ systems including CNS, liver, and heart. However, involvement of eye and thyroid is extremely rare. We present a case of 32-year old patient who presented with conjunctivitis and subacute thyroiditis and was found to have dengue viral infection as the cause of these conditions.


Assuntos
Conjuntivite Viral/diagnóstico , Vírus da Dengue/isolamento & purificação , Dengue/diagnóstico , Tireoidite Subaguda/diagnóstico , Antagonistas Adrenérgicos beta/uso terapêutico , Adulto , Conjuntivite Viral/tratamento farmacológico , Conjuntivite Viral/virologia , Dengue/tratamento farmacológico , Dengue/virologia , Vírus da Dengue/genética , Antagonistas dos Receptores Histamínicos/uso terapêutico , Humanos , Ibuprofeno/uso terapêutico , Masculino , Reação em Cadeia da Polimerase , Propranolol/uso terapêutico , Tireoidite Subaguda/tratamento farmacológico , Tireoidite Subaguda/virologia , Resultado do Tratamento
4.
J Investig Med High Impact Case Rep ; 4(2): 2324709616647085, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27200380

RESUMO

Immune thrombocytopenia (ITP) is the most common cause of isolated thrombocytopenia in healthy people. ITP may rarely coexist with autoimmune thyroid disorders, which may indicate more complex defect in immune system. Primary ITP usually responds well to steroids and intravenous immunoglobulins. However, ITP may be difficult to treat when associated with thyroid autoimmune disorders. In such cases, treating the underlying thyroid disorder may significantly improve platelet count and can either cause remission of disease or improve response to standard ITP therapy. We report a case of 47-year-old male who was diagnosed with ITP and was also found to have subclinical Hashimoto's thyroiditis. Treatment of subclinical hypothyroidism with levothyroxine in our patient significantly improved the platelets, thus successfully bringing the disease in remission.

7.
Iran J Public Health ; 44(11): 1550-2, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26744714

RESUMO

Crohn's disease is a type of chronic inflammatory bowel disease (IBD) of unknown etiology that may affect any part of the gastrointestinal tract from mouth to anus and shows extra-intestinal involvement. It characteristically shows skip lesions. This case report reported in 2014 describes a middle age Pakistani male known to have documented evidence of significant crohn's disease since past 18 years. He was diagnosed with multiple fistulas that are a rare entity of patients with crohn's disease, which is itself a rare disease in Asian countries.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...